Feed Insights Top Reports Pricing

⌘K

06:25:00·1381d

PRReleasevia Quantisnow

Johnson & Johnson Reports Q2 2022 Results

ByQuantisnow·Wall Street's wire, on your screen.

JNJ· Johnson & Johnson

Health Care

This insight was delivered by Quantisnow - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track JNJ (Johnson & Johnson) and more on Quantisnow.

Quantisnowquantisnow.com

Quantisnow streams SEC filings, FDA approvals, analyst ratings, insider trades, and press releases to retail investors in real time. This insight was curated and delivered from the Quantisnow live feed.

Companies

JNJ
Johnson & Johnson
Health Care

Recent analyst ratings

Apr 8UpdateTD Cowen$250.00
Jan 28UpdateMorgan Stanley$262.00
Nov 13UpdateScotiabank$230.00
Oct 20UpdateDaiwa Securities$203.00
Oct 3UpdateWells Fargo$212.00
Sep 23UpdateGuggenheim$206.00

Related

PR1h
Johnson & Johnson Appoints Ryan Koors as Vice President, Investor Relations
SEC2d
Johnson & Johnson filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
INSIDER2d
SEC Form 4 filed by Director Woods Eugene A.
INSIDER2d
SEC Form 4 filed by Director West Nadja
INSIDER2d
SEC Form 4 filed by Director Weinberger Mark A
INSIDER2d
SEC Form 4 filed by Director Pinto Daniel E
INSIDER2d
SEC Form 4 filed by Director Morikis John G
INSIDER2d
SEC Form 4 filed by Director Mcclellan Mark B.

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releases Analyst ratings Insider trading FDA SEC RSS feeds Follow on Google News

Top lists

Trending By market cap Active companies Insider purchases FDA approvals Short volume screener Sectors Market reports

Browse

By event category By exchange Earnings calendar Dividend tracker Insider tracker IPO calendar Compare stocks

Publish

Publish an article Amend a newsitem Pricing Guidelines Terms

Company

About Pricing Refer a trader25%Publish with us Contact

Legal

Terms of use Privacy policy Cookie policy

© 2026 quantisnow.com · Democratizing insights since 2022